Differentiated Service Delivery Models for Maintaining HIV Treatment and Prevention Services During Crisis and Disease Outbreaks: Lessons from the COVID-19 Pandemic.
(2024 Jul 25)
Curr HIV/AIDS Rep
Njuguna N, Akolo C, Anzala O, Baeten JM, Heffron R, Mugo NR, Bateganya M

Twice-Yearly Lenacapavir or Daily F/TAF for HIV Prevention in Cisgender Women.
(2024 Jul 24)
N Engl J Med
Bekker LG, Das M, Abdool Karim Q, Ahmed K, Batting J, Brumskine W, Gill K, Harkoo I, Jaggernath M, Kigozi G, Kiwanuka N, Kotze P, Lebina L, Louw CE, Malahleha M, Manentsa M, Mansoor LE, Moodley D, Naicker V, Naidoo L, Naidoo M, Nair G, Ndlovu N, Palanee-Phillips T, Panchia R, Pillay S, Potloane D, Selepe P, Singh N, Singh Y, Spooner E, Ward AM, Zwane Z, Ebrahimi R, Zhao Y, Kintu A, Deaton C, Carter CC, Baeten JM, Matovu Kiweewa F, PURPOSE 1 Study Team

HIV-1 infection kinetics, drug resistance, and long-term safety of pre-exposure prophylaxis with emtricitabine plus tenofovir alafenamide (DISCOVER): week 144 open-label extension of a randomised, controlled, phase 3 trial.
(2024 Jul 12)
Lancet HIV
Wohl DA, Spinner CD, Flamm J, Hare CB, Doblecki-Lewis S, Ruane PJ, Molina JM, Mills A, Brinson C, Ramgopal M, Clarke A, Crofoot G, Martorell C, Carter C, Cox S, Hojilla JC, Shao Y, Das M, Kintu A, Baeten JM, Grant RM, Mounzer K, Mayer K

Women's preferences for HIV prevention service delivery in pharmacies during pregnancy in Western Kenya: a discrete choice experiment.
(2024 Jul)
J Int AIDS Soc 27 Suppl 1(Suppl 1): e26301
Mugambi ML, Odhiambo BO, Dollah A, Marwa MM, Nyakina J, Kinuthia J, Baeten JM, Weiner BJ, John-Stewart G, Barnabas RV, Hauber B

Oral preexposure prophylaxis uptake, adherence, and persistence during periconception periods among women in South Africa.
(2024 Jul 15)
AIDS 38(9): 1342-1354
Matthews LT, Jaggernath M, Kriel Y, Smith PM, Haberer JE, Baeten JM, Hendrix CW, Ware NC, Moodley P, Pillay M, Bennett K, Bassler J, Psaros C, Hurwitz KE, Bangsberg DR, Smit JA